Shreya Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shreya Sharma has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ali Asgar Saleem Bhagat
Institute for Health Innovation & Technology (iHealthtech), National University of Singapore (NUS), MD6, 14 Medical Drive, #14-01, Singapore 117599, Singapore
3 shared publications - Arvind Iyer
Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
3 shared publications - Balaram Vishnu Subramani
School of Mathematics, Indian Institute of Science Education and Research, Thiruvananthapuram 695551, India
3 shared publications - Burhanuddin Sabuwala
Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India
3 shared publications - Debarka Sengupta
Department of Computational Biology, Indraprastha Institute of Information Technology-Delhi (IIIT-Delhi), Okhla, Phase III, New Delhi, 110020, India
3 shared publications - Jay West
Fluidigm Corporation, 2 Tower Place, Suite 2000, South San Francisco, CA 94080, USA
3 shared publications
Latest Publications
- Open Access
- 19 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (2) , 370
Erratum: Iyer, A., et al. Integrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells. J. Clin. Med. 2020, 9, 1206
- 19 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (2) , 370
Open AccessErratum: Iyer, A., et al. Integrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells. J. Clin. Med. 2020, 9, 1206
- Open Access
- 22 April 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (4) , 1206
Integrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells
We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic system for label-free enrichment of CTCs.
- 22 April 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (4) , 1206
Open AccessIntegrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells
We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic system for label-free enrichment of CTCs.
- Open Access
Integrative analysis and machine learning based characterization of single circulating tumor cells
We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic systems for label-free enrichment of CTCs.
Open AccessIntegrative analysis and machine learning based characterization of single circulating tumor cells
We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic systems for label-free enrichment of CTCs.